Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study

Abstract

The results suggest no new safety concerns, and the effectiveness might be similar to previously reported data in clinical trials. Therefore, bevacizumab is considered as one of the treatment options for patients with malignant glioma in real-world clinical practice.